Growth Metrics

Resmed (RMD) Net Cash Flow (2016 - 2025)

Resmed's Net Cash Flow history spans 17 years, with the latest figure at $30.5 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 75.52% year-over-year to $30.5 million; the TTM value through Dec 2025 reached $848.9 million, up 153.7%, while the annual FY2025 figure was $945.3 million, 7655.27% up from the prior year.
  • Net Cash Flow reached $30.5 million in Q4 2025 per RMD's latest filing, down from $174.5 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $402.8 million in Q1 2025 to a low of -$81.4 million in Q4 2021.
  • Average Net Cash Flow over 5 years is $57.8 million, with a median of $18.8 million recorded in 2022.
  • Peak YoY movement for Net Cash Flow: plummeted 454.16% in 2023, then soared 74796.27% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at -$81.4 million in 2021, then surged by 143.15% to $35.1 million in 2022, then plummeted by 120.69% to -$7.3 million in 2023, then soared by 1811.28% to $124.4 million in 2024, then plummeted by 75.52% to $30.5 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Net Cash Flow are $30.5 million (Q4 2025), $174.5 million (Q3 2025), and $241.2 million (Q2 2025).